ey0020.3-19 | Advances in Growth, Bone Biology, and Mineral Metabolism | ESPEYB20
M Chau , Z Dou , M Baroncelli , EB Landman , A Bendre , M Kanekiyo , A Gkourogianni , K Barnes , L Ottosson , O Nilsson
ey0020.9-5 | Advances in Understanding Central Weight Regulation and Behaviour | ESPEYB20
K Grzelka , H Wilhelms , S Dodt , ML Dreisow , JC Madara , SJ Walker , C Wu , D Wang , BB Lowell , H Fenselau
ey0020.9-16 | Patient Care: Bariatric Surgery, New Drugs, and Appropriate Language | ESPEYB20
K Jarvholm , A Janson , M Peltonen , M Neovius , E Gronowitz , M Engstrom , A Laurenius , AJ Beamish , J Dahlgren , L Sjogren , T Olbers
ey0020.10-6 | New Drugs for Children with T2DM | ESPEYB20
P Zeitler , L El Ghormli , S Arslanian , S Caprio , E Isganaitis , MK Kelsey , RS Weinstock , NH White , K Drews
ey0021.7-8 | Clinical Guidance and Studies | ESPEYB21
K Duckett , A Williamson , JWR Kincaid , K Rainbow , LJ Corbin , HC Martin , RY Eberhardt , QQ Huang , ME Hurles , W He , R Brauner , A Delaney , L Dunkel , RP Grinspon , JE Hall , JN Hirschhorn , SR Howard , AC Latronico , AAL Jorge , K McElreavey , V Mericq , PM Merino , MR Palmert , L Plummer , RA Rey , RC Rezende , SB Seminara , K Salnikov , I Banerjee , BYH Lam , JRB Perry , NJ Timpson , P Clayton , YM Chan , KK Ong , S O'Rahilly
ey0021.8-15 | New Hope | ESPEYB21
A Fischer , S Kloos , U Maccio , J Friemel , H Remde , M Fassnacht , C Pamporaki , G Eisenhofer , HJLM Timmers , M Robledo , SMJ Fliedner , K Wang , J Maurer , A Reul , K Zitzmann , N Bechmann , G Žygienė , S Richter , C Hantel , D Vetter , K Lehmann , H Mohr , NS Pellegata , M Ullrich , J Pietzsch , CG Ziegler , SR Bornstein , M Kroiss , M Reincke , K Pacak , AB Grossman , F Beuschlein , S Nolting
ey0021.15-16 | New Paradigms | ESPEYB21
K Ying , H Liu , AE Tarkhov , MC Sadler , AT Lu , M Moqri , S Horvath , Z Kutalik , X Shen , VN. Gladyshev
ey0018.8-8 | Clinical Trials – New Treatments | ESPEYB18
K Clement , E van den Akker , J Argente , A Bahm , WK Chung , H Connors , K De Waele , IS Farooqi , J Gonneau-Lejeune , G Gordon , K Kohlsdorf , C Poitou , L Puder , J Swain , M Stewart , G Yuan , M Wabitsch , P; Setmelanotide POMC and LEPR Phase 3 Trial Investigators Kuhnen
ey0019.5-3 | Novel treatments for rare skeletal disorders | ESPEYB19
R Savarirayan , L Tofts , M Irving , WR Wilcox , CA Bacino , J Hoover-Fong , RU Font , P Harmatz , F Rutsch , MB Bober , LE Polgreen , I Ginebreda , K Mohnike , J Charrow , D Hoernschemeyer , K Ozono , Y Alanay , P Arundel , Y Kotani , N Yasui , KK White , HM Saal , A Leiva-Gea , F Luna-Gonzalez , H Mochizuki , D Basel , DM Porco , K Jayaram , E Fisheleva , A Huntsman-Labed , JRS Day
ey0019.14-9 | Risk and Outcome | ESPEYB19
SA Williams , R Ostroff , MA Hinterberg , J Coresh , CM Ballantyne , K Matsushita , CE Mueller , J Walter , C Jonasson , RR Holman , SH Shah , N Sattar , R Taylor , ME Lean , S Kato , H Shimokawa , Y Sakata , K Nochioka , CR Parikh , SG Coca , T Omland , J Chadwick , D Astling , Y Hagar , N Kureshi , K Loupy , C Paterson , J Primus , M Simpson , NP Trujillo , P Ganz